Cecilia Fu

1.3k total citations
32 papers, 945 citations indexed

About

Cecilia Fu is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Cecilia Fu has authored 32 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 14 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Cecilia Fu's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (8 papers). Cecilia Fu is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Acute Myeloid Leukemia Research (8 papers). Cecilia Fu collaborates with scholars based in United States, Canada and India. Cecilia Fu's co-authors include Kathleen M. Sakamoto, Tara L. Lin, Agustı́n Rodrı́guez-González, Tiffany Simms-Waldrip, Alan K. Ikeda, Paul S. Gaynon, Michael E. Trigg, Janet Franklin, Paul Rogers and Nita L. Seibel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Clinical Nutrition.

In The Last Decade

Cecilia Fu

30 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecilia Fu United States	16	404	380	340	219	190	32	945
W. A. Kamps Netherlands	22	304 0.8×	519 1.4×	273 0.8×	316 1.4×	302 1.6×	29	1.2k
Y. Ravindranath United States	14	183 0.5×	157 0.4×	103 0.3×	140 0.6×	266 1.4×	25	625
Mathew J. Edick United States	13	294 0.7×	158 0.4×	97 0.3×	96 0.4×	92 0.5×	25	603
Jian‐Pei Fang China	14	269 0.7×	118 0.3×	99 0.3×	95 0.4×	301 1.6×	87	733
Eugenia Tsai United States	9	311 0.8×	96 0.3×	149 0.4×	148 0.7×	211 1.1×	28	1.1k
Thomas A Ratko United States	16	172 0.4×	151 0.4×	55 0.2×	143 0.7×	255 1.3×	32	813
V. Michael Whitehead Canada	18	465 1.2×	595 1.6×	259 0.8×	157 0.7×	403 2.1×	37	1.2k
Alexander Gural Israel	18	328 0.8×	85 0.2×	46 0.1×	136 0.6×	313 1.6×	48	885
Prasoon Agarwal Sweden	17	468 1.2×	52 0.1×	110 0.3×	108 0.5×	108 0.6×	35	829
Suwen Li China	13	314 0.8×	371 1.0×	465 1.4×	367 1.7×	131 0.7×	31	1.2k

Countries citing papers authored by Cecilia Fu

Since Specialization

Citations

This map shows the geographic impact of Cecilia Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Fu more than expected).

Fields of papers citing papers by Cecilia Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Fu. The network helps show where Cecilia Fu may publish in the future.

Co-authorship network of co-authors of Cecilia Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Fu. A scholar is included among the top collaborators of Cecilia Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Fu. Cecilia Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beauchemin, Melissa, Sheila Judge Santacroce, Jenny Ruiz, et al.. (2024). Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report. JNCI Cancer Spectrum. 8(4). 4 indexed citations

Raca, Gordana, et al.. (2016). Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia. Leukemia Research Reports. 6. 29–32. 1 indexed citations

Singer, A., Suzan L. Carmichael, Steve Selvin, et al.. (2016). Maternal diet quality before pregnancy and risk of childhood leukaemia. British Journal Of Nutrition. 116(8). 1469–1478. 19 indexed citations

Yeo, Kee Kiat, Paul S. Gaynon, Cecilia Fu, Alan S. Wayne, & Weili Sun. (2016). Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance. Journal of Pediatric Hematology/Oncology. 38(5). 345–349. 5 indexed citations

Walsh, Kyle M., Adam J. de Smith, Helen M. Hansen, et al.. (2015). A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Research. 75(22). 4884–4894. 31 indexed citations

Hsu, Ling‐I, Anand P. Chokkalingam, Farren Briggs, et al.. (2015). Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children. Cancer Causes & Control. 26(4). 609–619. 19 indexed citations

Kutny, Matthew A., Todd A. Alonzo, Robert B. Gerbing, et al.. (2015). Results of a Phase III Trial Including Arsenic Trioxide Consolidation for Pediatric Patients with Acute Promyelocytic Leukemia (APL): A Report from the Children's Oncology Group Study AAML0631. Blood. 126(23). 219–219. 3 indexed citations

Felsenstein, Susanna, Etan Orgel, Teresa Rushing, Cecilia Fu, & Jill A. Hoffman. (2014). Clinical and Microbiologic Outcomes of Quinolone Prophylaxis in Children With Acute Myeloid Leukemia. The Pediatric Infectious Disease Journal. 34(4). e78–e84. 26 indexed citations

Chalfant, James S, Michelle L. Smith, Peng Hu, et al.. (2012). Inverse association between brown adipose tissue activation and white adipose tissue accumulation in successfully treated pediatric malignancy. American Journal of Clinical Nutrition. 95(5). 1144–1149. 23 indexed citations

10.

Champagne, Martin, Cecilia Fu, Myron Chang, et al.. (2011). Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 57(1). 56–62. 42 indexed citations

11.

Chang, Vivian Y., Fabiola Quintero‐Rivera, Erin E. Baldwin, et al.. (2010). B‐Acute lymphoblastic leukemia and cystinuria in a patient with duplication 22q11.21 detected by chromosomal microarray analysis. Pediatric Blood & Cancer. 56(3). 470–473. 7 indexed citations

12.

Rodrı́guez-González, Agustı́n, Tara L. Lin, Alan K. Ikeda, et al.. (2008). Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6–Dependent Protein Degradation. Cancer Research. 68(8). 2557–2560. 142 indexed citations

13.

Simms-Waldrip, Tiffany, Agustı́n Rodrı́guez-González, Tara L. Lin, et al.. (2008). The aggresome pathway as a target for therapy in hematologic malignancies. Molecular Genetics and Metabolism. 94(3). 283–286. 56 indexed citations

14.

Zape, Joan P., et al.. (2008). Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Suppresses Proliferation of Ba/F3 FLT-3 ITD Mutant Cells in Vitro and in Vivo through Inhibition of FLT3 and AKT.. Blood. 112(11). 1938–1938.

15.

Franklin, Janet, Nita L. Seibel, Mark Krailo, et al.. (2007). Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: A Children's Oncology Group report. Pediatric Blood & Cancer. 50(3). 533–536. 2 indexed citations

16.

Fu, Cecilia & Kathleen M. Sakamoto. (2007). PEG-asparaginase. Expert Opinion on Pharmacotherapy. 8(12). 1977–1984. 78 indexed citations

17.

Cheng, Jerry C., et al.. (2007). Potential Role of Creb As A Prognostic Marker In Acute Myeloid Leukemia. Future Oncology. 3(4). 475–480. 19 indexed citations

18.

Gaynon, Paul S., Antonia Periclou, Cecilia Fu, et al.. (2006). Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG‐1941). Pediatric Blood & Cancer. 47(2). 141–146. 42 indexed citations

19.

Avramis, Vassilios I., Eduard H. Panosyan, Cecilia Fu, Linda C. Stork, & Paul S. Gaynon. (2004). Pharmacodynamic (PD) Analyses of Asparagine (Asn) Deamination and Asn Input (Imax) in Serum of Pediatric Patients with Standard Risk Acute Lymphoblastic Leukemia (SR ALL) Receiving Native or Pegylated E. Coli Asparaginases (ASNase) (CCG-1962).. Blood. 104(11). 2082–2082. 1 indexed citations

20.

Martín‐Aragón, Sagrario, et al.. (2000). Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.. PubMed. 20(1A). 139–50. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact